Cargando…

The incidence of consecutive manifestations in Von Hippel-Lindau disease

Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unc...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst-Schrivers, Anouk N. A., Sluiter, Wim J., Kruizinga, Roeliene C., van Leeuwaarde, Rachel S., Giles, Rachel, Olderode-Berends, Maran J. W., Links, Thera P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560011/
https://www.ncbi.nlm.nih.gov/pubmed/31087189
http://dx.doi.org/10.1007/s10689-019-00131-x
_version_ 1783425882416742400
author van der Horst-Schrivers, Anouk N. A.
Sluiter, Wim J.
Kruizinga, Roeliene C.
van Leeuwaarde, Rachel S.
Giles, Rachel
Olderode-Berends, Maran J. W.
Links, Thera P.
author_facet van der Horst-Schrivers, Anouk N. A.
Sluiter, Wim J.
Kruizinga, Roeliene C.
van Leeuwaarde, Rachel S.
Giles, Rachel
Olderode-Berends, Maran J. W.
Links, Thera P.
author_sort van der Horst-Schrivers, Anouk N. A.
collection PubMed
description Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unclear. In this study we aimed to gain insight into the development of subsequent manifestations in VHL disease. We retrospectively scored each new VHL-related manifestation as detected by standard follow-up (retina, central nervous system, kidneys and pancreas, excluding adrenal and endolymfatic sac manifestations) in 75 VHL mutation carriers. The Kaplan–Meier method was used to plot the cumulative proportions of all consecutive manifestations in each organ against age. The cumulative average number of manifestations in all organs during life was calculated by summating these cumulative proportions. Poisson model parameters were used to calculate average time to the detection of consecutive VHL manifestations in each organ. Consecutive VHL-related kidney and retina manifestations during life occur linearly according to Poisson distribution model. The total number of VHL manifestations rises linearly, with an average of seven VHL-related lesions at age 60 years. The incidence of consecutive VHL-related manifestations is constant during life in VHL mutation carriers. Our data is consistent with the notion that somatic inactivation of the remaining allele (Knudson’s “two-hit” hypothesis) is the determining factor in developing new VHL-related manifestations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10689-019-00131-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6560011
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-65600112019-06-26 The incidence of consecutive manifestations in Von Hippel-Lindau disease van der Horst-Schrivers, Anouk N. A. Sluiter, Wim J. Kruizinga, Roeliene C. van Leeuwaarde, Rachel S. Giles, Rachel Olderode-Berends, Maran J. W. Links, Thera P. Fam Cancer Original Article Von Hippel-Lindau (VHL) disease is an autosomal dominant rare tumor syndrome characterized by high penetrance. VHL mutation carriers develop numerous manifestations in multiple organs during life. The natural course of development of new and growth of existing VHL-related manifestations is still unclear. In this study we aimed to gain insight into the development of subsequent manifestations in VHL disease. We retrospectively scored each new VHL-related manifestation as detected by standard follow-up (retina, central nervous system, kidneys and pancreas, excluding adrenal and endolymfatic sac manifestations) in 75 VHL mutation carriers. The Kaplan–Meier method was used to plot the cumulative proportions of all consecutive manifestations in each organ against age. The cumulative average number of manifestations in all organs during life was calculated by summating these cumulative proportions. Poisson model parameters were used to calculate average time to the detection of consecutive VHL manifestations in each organ. Consecutive VHL-related kidney and retina manifestations during life occur linearly according to Poisson distribution model. The total number of VHL manifestations rises linearly, with an average of seven VHL-related lesions at age 60 years. The incidence of consecutive VHL-related manifestations is constant during life in VHL mutation carriers. Our data is consistent with the notion that somatic inactivation of the remaining allele (Knudson’s “two-hit” hypothesis) is the determining factor in developing new VHL-related manifestations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10689-019-00131-x) contains supplementary material, which is available to authorized users. Springer Netherlands 2019-05-13 2019 /pmc/articles/PMC6560011/ /pubmed/31087189 http://dx.doi.org/10.1007/s10689-019-00131-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
van der Horst-Schrivers, Anouk N. A.
Sluiter, Wim J.
Kruizinga, Roeliene C.
van Leeuwaarde, Rachel S.
Giles, Rachel
Olderode-Berends, Maran J. W.
Links, Thera P.
The incidence of consecutive manifestations in Von Hippel-Lindau disease
title The incidence of consecutive manifestations in Von Hippel-Lindau disease
title_full The incidence of consecutive manifestations in Von Hippel-Lindau disease
title_fullStr The incidence of consecutive manifestations in Von Hippel-Lindau disease
title_full_unstemmed The incidence of consecutive manifestations in Von Hippel-Lindau disease
title_short The incidence of consecutive manifestations in Von Hippel-Lindau disease
title_sort incidence of consecutive manifestations in von hippel-lindau disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560011/
https://www.ncbi.nlm.nih.gov/pubmed/31087189
http://dx.doi.org/10.1007/s10689-019-00131-x
work_keys_str_mv AT vanderhorstschriversanoukna theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT sluiterwimj theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT kruizingaroelienec theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT vanleeuwaarderachels theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT gilesrachel theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT olderodeberendsmaranjw theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT linkstherap theincidenceofconsecutivemanifestationsinvonhippellindaudisease
AT vanderhorstschriversanoukna incidenceofconsecutivemanifestationsinvonhippellindaudisease
AT sluiterwimj incidenceofconsecutivemanifestationsinvonhippellindaudisease
AT kruizingaroelienec incidenceofconsecutivemanifestationsinvonhippellindaudisease
AT vanleeuwaarderachels incidenceofconsecutivemanifestationsinvonhippellindaudisease
AT gilesrachel incidenceofconsecutivemanifestationsinvonhippellindaudisease
AT olderodeberendsmaranjw incidenceofconsecutivemanifestationsinvonhippellindaudisease
AT linkstherap incidenceofconsecutivemanifestationsinvonhippellindaudisease